A Study of CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Matthew B. Rettig, MD
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- San Francisco Va Medical Center, San Francisco, Ca
San Francisco, California, United States
- Va Greater Los Angeles Healthcare System, West Los Angeles, Ca
West Los Angeles, California, United States
- Washington Dc Va Medical Center, Washington, Dc
Washington D.C., District of Columbia, United States
- Bay Pines Va Healthcare System, Pay Pines, Fl
Bay Pines, Florida, United States
- Jesse Brown Va Medical Center, Chicago, Il
Chicago, Illinois, United States
- Va Ann Arbor Healthcare System, Ann Arbor, Mi
Ann Arbor, Michigan, United States
- Manhattan Campus of the Va Ny Harbor Healthcare System, New York, Ny
New York, New York, United States
- James J. Peters Va Medical Center, Bronx, Ny
The Bronx, New York, United States
- Durham Va Medical Center, Durham, Nc
Durham, North Carolina, United States
- Va Portland Health Care System, Portland, Or
Portland, Oregon, United States
- Corporal Michael J. Crescenz Va Medical Center, Philadelphia, Pa
Philadelphia, Pennsylvania, United States
- Hunter Holmes Mcguire Va Medical Center, Richmond, Va
Richmond, Virginia, United States
- Va Puget Sound Health Care System Seattle Division, Seattle, Wa
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Feb 2020
- Primary completion
- 2 Feb 2026
- Completion
- 31 Dec 2026
- Last update posted
- 27 Feb 2026
- Registered enrollment
- 40
- Registry id
- NCT04104893
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.